Therefore, inhibitors of AKT and PIK3CA are used in Poteus and Proteus-like syndromes and PIK3CA related over growth disorders.422,424,425 In addition, constitutional PTEN pathway dysfunction theoretically requires some kind of chronic treatment program. This evidence concerns the gene PIK3CA and Proteus-like syndrome.